The psychobiotic revolution has arrived
Looking for a way to kick the blues, quell the jitters or adjust your mood?
Then learn how to nurture your microbiome - the trillions of microbes living inside your digestive system.
The term "psychobiotics" was coined by cofounder Ted Dinan to describe the effect of gut bacteria and other biologics on the brain through the gut-brain axis.
Along with John Cryan, they have led the development of the field of gut-brain science for almost 15 years, and are now creating their first spin out firm based on their research.
The firm will conduct R&D and commercialise a pipeline of science-based patented strains, starting with "Bifidobacterium longum APC1472" , the team's first psychobiotic.
Bifidobacterium longum APC1472
Studies have moved from initial laboratory studies, through pre-clinical mouse trials to a large-scale human intervention trial involving 124 subjects, all described in a Lancet article below.
Psychobiotics is currently in the process of forming a spin out from University College Cork (UCC), expected in Q1 2022, where UCC and the founders will share the firm’s equity.Following this spin out, the firm will raise a seed round to:
- Build marketing materials for online and offline brand building
- Manufacture and package the first capsules for sale through contract manufacturers
- Purchase shelf space in online / offline retail channels
- Engage full operational team to work from incubator space in UCC
- Build next generational platform of microbiome products